IL4 and B-cell chronic lymphocytic leukemia: Co-culture with HS5 genetically engineered to simultaneously express CD40L and IL4 led to mild CLL cell proliferation (~7%), while the HS5 expressing CD40L, IL4, and IL21 led to a consistently high CLL proliferation rate (~44% at day 7).